Failure of Test. If a Generator fails any test, it shall be disabled and the Isolation Device must be opened until the equipment is repaired.
Failure of Test. If a Distributed Resource fails any test, it shall be disabled and the Isolation Device must be opened until the equipment is repaired.
Failure of Test. If Customer’s System fails any test, it shall be disabled and the Isolation Device must be opened until the equipment is repaired and successfully passes the required testing.
Failure of Test. Subject to paragraph (d), if the results of a Test indicate that the SRAS is Unavailable, the SRAS will have failed that Test and is taken to have been Unavailable for the period determined under clause 5.2(c). If the results of a Test clearly indicate a material failure to provide the Contracted Electricity Export Capability substantially within the time specified in the Contracted Levels of Performance, the SRAS will have failed that Test and the SRAS Provider must immediately give a notice to AEMO under clause 5.2(a). At any time after a Test and up to 10 business days after receiving a test report under clause 6.3, AEMO may notify the SRAS Provider, in AEMO’s reasonable opinion: whether the Test demonstrates that the SRAS was Available or Unavailable; and if Unavailable, whether any identified non-compliance with the Contracted Levels of Performance or Minimum Technical Requirements would have materially affected the ability to provide the SRAS, provided that if paragraph (b) does not apply and AEMO does not give notice under this paragraph (c) within 10 business days after receiving the test report, the SRAS is taken to have passed the Test (Available). If AEMO’s notice under paragraph (c) indicates that the non-compliance with the Contracted Levels of Performance or Minimum Technical Requirements would not have materially affected the ability to provide the SRAS, then the SRAS is taken to have failed that Test if, and only if: the result of a repeat Test conducted within 20 business days of the date of AEMO’s notice also indicates that the SRAS is Unavailable (whether or not for the same reason); or a repeat test is not conducted within 20 business days after the date of AEMO’s notice.
Failure of Test. (a) Subject to paragraph (b), if the results of a Test indicate that the SRAS is Unavailable, the SRAS Equipment will have failed that Test.
(b) If AEMO reasonably determines that any fault identified in a Test under paragraph (a) is unlikely to materially affect the capability to provide the SRAS, then the SRAS Equipment is taken to have failed that Test if, and only if:
(i) the result of a repeat Test conducted within 20 business days of the original Test also indicates that the SRAS is Unavailable; or
(ii) a repeat test is not conducted within 20 business days after the original Test.
(c) If SRAS Equipment fails a Test, the relevant SRAS will be taken to have been Unavailable for the period determined under clause 5.2(c).
Failure of Test. Employees' records will be reviewed by the Ad Hoc committee for the appropriate actions which may be displacement, demotion, or other actions.
Failure of Test. In the event of a delivery of the Product failing testing and release in accordance with the terms of a marketing authorisation, MediGene shall promptly notify CollaGenex and furnish CollaGenex with the test results. CollaGenex shall then be afforded not less than [**] but no more than [**] Business Days to re-perform all relevant tests (including microbial tests) from retained samples of the relevant batch. CollaGenex shall furnish MediGene with a copy of its re-test results as soon as they are available. In the event of confirmation, by re-test, that the batch does not meet the specifications of the marketing authorisation, then CollaGenex shall take back the Product and promptly [**] with CollaGenex meeting the [**] to the Territory within [**] Calendar Days of the provision of the re-test results to MediGene.
